Page 3 - Exceptional Items News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sun Pharmaceutical Industries (Sun Pharma) reported a turnaround in the January-March quarter of the 2022-23 financial year (Q4FY23), declaring a profit after tax (PAT) of Rs 1,984 crore versus a loss of Rs 2,277 crore in Q4FY22. However, that loss in FY22 was due to several exceptional one-time items -- with Rs 3,723.15 crore allocated to settlement of lawsuits in the US and other Exceptional Items adding up to Rs 3,935.75 crore. Adjusted for exceptional items, PAT in Q4FY22 amounts to Rs 2,155 crore, which is a year-on-year (YoY) growth of about 36 per cent.

UK Inflation to Be Among Highest in Major Economies in 2023, OECD Says 1133 GMT - The U.K. is set to have one of the highest rates of inflation among major global economies this year, according... | June 7, 2023

The FTSE 100 Index closed Wednesday marginally down, 0.05% or 3.7 points to 7624, as property stocks offset the rise on the oil-exposed sector on the back of negative house-prices data. The index's dull performance was in line with global peers amid ri... | 12:10pm

Singapore dominant telecom operator Singtel last week announced that net profit for the financial year which ended March 2023 was up 14 per cent to SGD 2.23 b

New Delhi, May 17: RailTel on Wednesday announced its Consolidated Operating Income of Rs 704 Crore in the fourth quarter of FY 22-23 with a growth of 55 per cent quarter on quarter in its 139th Board Meeting.